- Home
- AMBP vs LGND Comparison
AMBP vs LGND Comparison
Compare AMBP & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBP
- LGND
- Stock Information
- Founded
- AMBP 2021
- LGND 1987
- Country
- AMBP Luxembourg
- LGND United States
- Employees
- AMBP N/A
- LGND N/A
- Industry
- AMBP Containers/Packaging
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- AMBP Industrials
- LGND Health Care
- Exchange
- AMBP Nasdaq
- LGND Nasdaq
- Market Cap
- AMBP 1.9B
- LGND 2.1B
- IPO Year
- AMBP N/A
- LGND 1992
- Fundamental
- Price
- AMBP $3.74
- LGND $104.48
- Analyst Decision
- AMBP Buy
- LGND Strong Buy
- Analyst Count
- AMBP 4
- LGND 8
- Target Price
- AMBP $3.30
- LGND $144.71
- AVG Volume (30 Days)
- AMBP 2.4M
- LGND 104.5K
- Earning Date
- AMBP 04-24-2025
- LGND 05-08-2025
- Dividend Yield
- AMBP 10.72%
- LGND N/A
- EPS Growth
- AMBP N/A
- LGND N/A
- EPS
- AMBP N/A
- LGND N/A
- Revenue
- AMBP $5,035,000,000.00
- LGND $181,488,000.00
- Revenue This Year
- AMBP $4.65
- LGND $16.47
- Revenue Next Year
- AMBP $2.39
- LGND $19.44
- P/E Ratio
- AMBP N/A
- LGND N/A
- Revenue Growth
- AMBP 4.42
- LGND 53.40
- 52 Week Low
- AMBP $2.50
- LGND $72.61
- 52 Week High
- AMBP $4.26
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- AMBP 68.52
- LGND 46.11
- Support Level
- AMBP $3.47
- LGND $99.24
- Resistance Level
- AMBP $3.77
- LGND $107.37
- Average True Range (ATR)
- AMBP 0.16
- LGND 4.05
- MACD
- AMBP 0.02
- LGND -0.33
- Stochastic Oscillator
- AMBP 92.95
- LGND 39.37
About AMBP Ardagh Metal Packaging S.A.
Ardagh Metal Packaging SA is a supplier of infinitely recyclable, sustainable, metal beverage cans and ends to brand owners. Its segment includes Europe and the Americas. It derives a majority of its revenue from the Americas.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.